| Iupac Name: | [(8''R'',9''S'',10''R'',13''S'',14''S'',17''S'')-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[''a'']phenanthren-17-yl] 3-phenylpropanoate |
| Width: | 250px |
| Width2: | 250px |
| Tradename: | Testolent, Sustanon 100, Sustanon 250, Omnadren 250 |
| Routes Of Administration: | Intramuscular injection |
| Cas Number: | 1255-49-8 |
| Pubchem: | 14743 |
| Drugbank: | DB16003 |
| Chemspiderid: | 14062 |
| Unii: | 8GN84GWX51 |
| Chembl: | 2356993 |
| Kegg: | D08574 |
| Synonyms: | TPP; Testosterone phenpropionate; Testosterone hydrocinnamate |
| C: | 28 |
| H: | 36 |
| O: | 3 |
| Smiles: | C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CC[C@]35C |
| Stdinchi: | 1S/C28H36O3/c1-27-16-14-21(29)18-20(27)9-10-22-23-11-12-25(28(23,2)17-15-24(22)27)31-26(30)13-8-19-6-4-3-5-7-19/h3-7,18,22-25H,8-17H2,1-2H3/t22-,23-,24-,25-,27-,28-/m0/s1 |
| Stdinchikey: | HHSXYDOROIURIP-FEZCWRLCSA-N |
Testosterone phenylpropionate (; TPP) (brand name Testolent), or testosterone phenpropionate, also known as testosterone hydrocinnamate, is a synthetic anabolic-androgenic steroid (AAS) and an androgen ester – specifically, the C17β phenylpropionate ester of testosterone – which was formerly marketed in Romania.[1] [2] [3] [4] It was first synthesized in 1951 and was first described in the literature by 1953.[5] The medication was an ingredient of several isolated AAS commercial products, but was never widely used. Testosterone phenylpropionate was also notably a component of Sustanon and Omnadren, as well as of Estandron Prolongatum, Lynandron Prolongatum, and Mixogen.[6] TPP was previously available in Great Britain.[7]